2022-06-16
Latest: Revealing Nervonic acid molecules as core molecular markers of cardiogenic or atherosclerotic thrombosis
Recently, the research group of Liqun Jiao, director of Xuanwu Hospital, Capital Medical University, and the research team of Xianyang Chen, CTO of Bao Feng Biotech, published a paper in the Journal of neurointerventional surgery, revealing that the nervonic acid molecule "Galabiosylceramide (18:1/24:1)" is a core molecular marker for differentiating cardiogenic thrombosis from atherosclerotic thrombosis.